Efficacy and safety of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: a single center experience

Background and aims: Portal hypertension and hepatocellular carcinoma (HCC) are major complications of advanced liver cirrhosis. As HCC typically represents a late-stage complication of liver cirrhosis, most of these patients are also affected by symptomatic portal hypertension. Transjugular intrahepatic portosystemic shunt (TIPS) is an effective treatment for portal hypertension and its complications. However, no established guidelines for the treatment of portal hypertension in HCC patients are currently available and only limited information exists about the consequence of TIPS implantation in patients with H…